INNOFARMA RU, OOO, Moscow

Economic indicators

Net profit (RAS) of INNOFARMA RU, OOO made up 0 RUB over 2021 compared to net loss of 9.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 4.00 thousand RUB in 2020; sales profit made up 0 RUB compared to 4.00 thousand RUB.

Net loss (RAS) of INNOFARMA RU, OOO dropped over 2020 7.00 times to 9.00 thousand RUB from 63.00 thousand RUB KAgent.Entities.Balance, the company informed.

Sales profit made up 4.00 thousand RUB compared to sales loss of 19.00 thousand RUB.

Net loss (RAS) of INNOFARMA RU, OOO increased 9.00 times to 63.00 thousand RUB from 7.00 thousand RUB over 2018, the company informed.

Sales loss grew by 11.76% to 19.00 thousand RUB from 17.00 thousand RUB.

Net loss (RAS) of INNOFARMA RU, OOO dropped over 2018 4.86 times to 7.00 thousand RUB from 34.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 792.00 thousand RUB in 2017; sales loss decreased 90.29 times to 17.00 thousand RUB from 1.54 million RUB.

Net loss (RAS) of INNOFARMA RU, OOO increased 5.67 times to 34.00 thousand RUB from 6.00 thousand RUB over 2016, the company informed.

Revenue decreased in the accounting period by 11.11% to 792.00 thousand RUB from 891.00 thousand RUB in 2016; sales loss grew 20.47 times to 1.54 million RUB from 75.00 thousand RUB.

Net loss (RA) of INNOFARMA RU, OOO made up 6.00 thousand RUB over 2016 compared to net profit of 49.00 thousand RUB over 2015, the company informed.

Revenue increased in the accounting period by 32.20% to 891.00 thousand RUB from 674.00 thousand RUB over 2015; sales loss decreased 3.57 times to 75.00 thousand RUB from 268.00 thousand RUB.

Companies in the region

• LITEKS
• GROSS TREYD
• VEKTOR-PLYUS
• VITA SERVIS
• MERIDIAN